R(+)-SKF-81297 HYDROBROMIDE SELECTIVE D1 DOPAMINE

R(+)-SKF-81297 HYDROBROMIDE SELECTIVE D1  DOPAMINE Struktur
253446-15-0
CAS-Nr.
253446-15-0
Englisch Name:
R(+)-SKF-81297 HYDROBROMIDE SELECTIVE D1 DOPAMINE
Synonyma:
R(+)-SKF-81297;R(+)-SKF-81297 HYDROBROMIDE SELECTIVE D1 DOPAMINE;(5R)-9-chloro-5-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
CBNumber:
CB2972828
Summenformel:
C16H16ClNO2.BrH
Molgewicht:
370.672
MOL-Datei:
253446-15-0.mol

R(+)-SKF-81297 HYDROBROMIDE SELECTIVE D1 DOPAMINE Eigenschaften

Löslichkeit
H2O: soluble6mg/mL
Aggregatzustand
solid
Farbe
white to off-white
Optische Aktivität
[α]22/D +15.14°, c = 0.52 in DMF(lit.)

Sicherheit

WGK Germany  3

R(+)-SKF-81297 HYDROBROMIDE SELECTIVE D1 DOPAMINE Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

R(+)-SKF-81297 Hydrobromide is a dopamine D1 agonist.

Biochem/physiol Actions

SKF-81297 administration in spontaneously hypertensive rats (SHR) induces an increase in expression of proto-oncogene c-fos mRNA leading to biphasic effect on locomotion. It favors the turnover of phosphoinositide and adenylyl cyclase. SKF-81297 is involved in the stimulation of neurons, in particular the postsynaptic striatal neurons.

R(+)-SKF-81297 HYDROBROMIDE SELECTIVE D1 DOPAMINE Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


R(+)-SKF-81297 HYDROBROMIDE SELECTIVE D1 DOPAMINE Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 7)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Aladdin Scientific
+1-833-552-7181
sales@aladdinsci.com United States 52927 58
Sigma-Aldrich 021-61415566 800-8193336
orderCN@merckgroup.com China 51471 80
Shanghai Anhua Biotechnology Co., Ltd. 021-61263375 18168859245
China 5958 58
Wuxi maimo topp biotechnology co., LTD 15861600115
lisa-li@mimotopes.cn China 5854 58

  • R(+)-SKF-81297 HYDROBROMIDE SELECTIVE D1 DOPAMINE
  • R(+)-SKF-81297
  • (5R)-9-chloro-5-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
  • 253446-15-0
Copyright 2019 © ChemicalBook. All rights reserved